Try our Advanced Search for more refined results
Life Sciences - February, 2024
275 articles
- Medtronic Expands Its Bladder Device Patent Fight
- Judge Wary Of Wading Into AG's 'Abortion Pill Reversal' Probe
- BlossomHill Therapeutics Closes $100M Series B
- Sandoz To Pay $265M To Resolve Claims In Price-Fixing MDL
- Auto Co. Says $50M Policy Endorsement Covers COVID Loss
- McCarter & English Wants Ex-Client To Cough Up Extra $1.8M
- Medtronic Says 3 Years Of Tax Returns Under IRS Audit
- Bankrupt Endo To Pay $465M To Resolve Opioid Claims
- 7 Common Myths About Lateral Partner Moves
- Biotech Co., Ex-Exec And Investor To Pay $5.2M In SEC Suit
- Cravath Steers Viatris' $350M Collab With Swiss Co.
- Fish & Richardson Adds Ex-Jenner & Block Life Sciences Duo
- Scrubs Co. Must Arbitrate With Its Ex-Atty Over False Ad Loss
- Judge Says Ermi Counterclaims In Qui Tam Case Can Stand
- Cheering In The NFL Makes Me A Better Lawyer
- WilmerHale Adds Ex-Medtronic Legal Leader To Its DC Office
- 3rd Circ. Won't Rehear Pfizer Shareholder Suit Coverage Row
- Dexcom Rival Fights Its Bid To Tweak Glucose Monitor Patent
- NuVasive Can Pierce Co. To Collect From Ex-Rep, Judge Says
- J&J's CMO Says He Would've Pulled Talc If It Caused Cancer
- Last-Minute Settlement Stops 2nd Catheter Trial In Del.
- Judge Trims Medical Device Royalty Fight
- Hospital Groups Allege Opioid Crisis Damaged Their Finances
- Veradigm To Acquire ScienceIO, Face Potential Nasdaq Delisting
- Monsanto Wants Further 11th Circ. Roundup Suit Review
- 10th Circ. Backs FDA E-Cigarettes Marketing Denial
- Survey Finds Just 4 in 10 Healthcare Orgs. Review AI Guidance
- Args In APA Case Amplify Justices' Focus On Agency Power
- Ga. Judge Pauses $300M Bond Deadline In Monkey Farm Fight
- Arnold & Porter Transactions Vet Joins Foley & Lardner
- Fox Rothschild Taps Sarasota-Area Firm Attys For New Office
- Latham, Jackson Walker Avoid Sanctions Over Sorrento Venue
- Altria Unit Drops Suit Against Dozens Of Vape Makers
- Sales Reps Score $1.6M In Fees After Beating RICO Case
- Bayer Beats Flintstone Vitamin Buyers' Cert. Bid, For Now
- Medical Device Companies Settle Ga. Wrongful Death Suit
- 'Rebel Alliance' Seeks Court Rescue In Opioid Discovery Clash
- Teva Tells 1st Circ. Feds Must Clear High Bar In FCA Case
- Stimwave Prosecutors Accused Of Brady Violation Mid-Trial
- ESG Around The World: Gulf Cooperation Council
- J&J Bankruptcy Could Thwart Accountability For Victims
- Ropes & Gray-Led THL Taking Agiliti Private In $2.5B Deal
- Catching Up With Delaware's Chancery Court
- 1 Pilot For Billionaire Cops Plea, But 2nd Says He's Innocent
- Paul Hastings Adds FDA Practice Chair From King & Spalding
- Cannabis Workers Say Co. Imposed Quotas, Didn't Pay Up
- Chamber's Report Bemoans Biden's March-In Idea For Drug IP
- Healthcare AI Startup Abridge Raises $150M
- 8th Circ. Says Nursing Home Fraudster Owes Supplier $7.6M
- J&J Unit Assails Knee Replacement IP Verdict At Fed. Circ.
- Inside The PTAB's Seagen Cancer Drug Patent Decision
- Walgreens Investors Near Deal In Suit Over Opioid Epidemic
- Judge Nixes McCarter & English Client's Relief Bid In Fee Row
- 6 Pointers For Attys To Build Trust, Credibility On Social Media
- Eye Care Tech Co. Gets Go-Ahead For April Sale In Ch. 11
- Holland & Knight Product Liability Ace Rejoins Reed Smith
- Family Dollar Accused Of Knowingly Selling Unsafe Drugs
- SEC Won't Force BofA To Act On ESG Critic's Proxy Proposal
- Justices Urged To Affirm Limits On Mifepristone Access
- IP Forecast: Samsung Eyes Ex-Attys' Litigation Funder Chats
- NYC Doc Charged Over $20M Lab-Fraud Kickback Scheme
- First-Ever Anti-Doping Act Defendant Sentenced To 3 Months
- Gilead Reaches Deal In Suit Over Counterfeit HIV Drug
- Invisalign Maker Beats Refusal-To-Deal Claims In 3Shape Row
- 3rd Circ. Won't Protect AbbVie's Atty-Client Communications
- Opioid Drug Co. Sued In Del. For Promotion-Tied Stock Drop
- Apple Gets PTAB Wins On 2 Masimo Blood Oxygen Patents
- Sorrento Says US Trustee's Protest Of Texas Venue Off Base
- Biotech VC Firm ORI Capital Closes $260M Fund
- Mich. Judge OKs $52M Deal For Mayo Foundation Subscribers
- Biden Admin's March-In Plan Would Hurt Medical Innovation
- Deals Rumor Mill: Occidental, Kroger-Albertsons, BuzzFeed
- 39 AGs Call For Federal Pharmacy Benefit Manager Reform
- Former Exec Convicted Of Medtronic Insider Trading Scheme
- FDA Let Pharma Co. 'Sidestep' Application Rules, Court Told
- Actelion Cites FDA Safety Rules Against Tracleer Antitrust Suit
- A Post-Mortem Analysis Of Stroock's Demise
- Kratom Buyers Say Sellers Hid Opioid-Like Addiction Risks
- Liberal Justices Hint Chevron Deference Hanging By A Thread
- 2nd Circ. Won't Restore Allergan Investors' Breast Implant Suit
- High Court Blocks Bid By 3 States To Join Abortion Drug Case
- Fluoride Trial Judge Mulls 'Mixed' IQ Evidence In Closings
- US Trustee Wants Sorrento Ch. 11 Tossed Or Relocated
- Ala. Justices Deem Frozen Embryos Children Under State Law
- Patent Atty Group Supports Vanda In High Court Patent Case
- FDA Flags 'Alarming Trend' Of Bad Data In Med Device Testing
- Biotech Co. SomaLogic, Former Exec Settle Fight Over Stock
- Biology AI Startup Bioptimus Raises $35M Seed Round
- Ga. Justices Clarify Official's Role In Hospital Expansion Law
- Pharma Co. Can Get D&O Coverage For Securities Suit
- Fed. Circ. Backs Microsoft's PTAB Win Over 3D Patents
- What's On The Horizon In Attorney General Enforcement
- Latham Adds Cooley Company Growth Pros In San Francisco
- Justices Shoot Down Drugmaker's PTAB Preclusion Challenge
- Preparing For DOJ's Data Analytics Push In FCPA Cases
- High Court Won't Review PTAB's Ax Of Prof's Ventilator Patent
- Judge Seeks Briefing On New Expert Proposed In Tylenol MDL
- Athira Pharma Investors Win OK Of $10M Deal On Second Try
- NC's Stein Supports Abortion Drug Manufacturer In W.Va. Case
- The Congressman Who Reps Cannabis Reform On Capitol Hill
- Va. Couple Sues CooperSurgical Over Destroyed Embryos
- Catching Up With Delaware's Chancery Court
- Reducing The Risk Of PFAS False Advertising Class Actions
- Ape Farm Says Ga. Officials Monkeying With $300M Bond Deal
- Chromocell Hits Stock Markets Following $6.6M IPO
- Medtronic Urges 8th Circ. To Undo Transfer Pricing Ruling
- Taxation With Representation: Paul Weiss, Kirkland
- UK Litigation Roundup: Here's What You Missed In London
- 'Body Sculpting' Device Co. Faces Investor Suit Over Pricing
- IP Forecast: 'No Labels' Party Feuds With Website Over Name
- House Committee Blasts VA, Oracle For E-Record Failures
- DOJ Fights 'Outdated' Tenn. Law On HIV-Positive Sex Workers
- Citadel Securities, Others Beat Biotech Spoofing Suit, For Now
- HHS Targets Biz Group's Standing In Bid To End Medicare Suit
- Profs Say W.Va. Mifepristone Ban 'Out Of Step' With Regs
- Invitae Can Use Cash Collateral For Speedy Ch. 11
- Court Mulls If Claims Buyer Qualifies For Special Ch. 11 Trust
- Freenome Raises $254M For Early Cancer Detection Tests
- Lincare To Pay $25.5M To Settle FCA, Anti-Kickback Litigation
- Aurinia Refocusing After Failed Effort To Find A Buyer
- Med Monitoring Claims In Philips MDL Sent Back For Review
- FTC's Khan Calls Healthcare 'Key' To Fight For Competition
- Pfizer Reaches $93M Deal With Lipitor Buyers In Antitrust MDL
- Alcon Can't Dodge Suit Over Eye Drops' '30 Day Supply' Claim
- Karuna Faces Investor Suit Over $14B Bristol Myers Buyout
- FTC Seeks Info On 'Powerful Middlemen' Amid Drug Shortages
- Adagio Medical Goes Public In $128M SPAC Merger
- Software Co. Inks $4M Deal In Privacy Suit Over Breached Info
- Pharma Co. Humanigen Gets OK For Ch. 11 Sale
- Breast Implant Co. Wants Ch. 11 Sale Closed In 60 Days
- Drug Co. Paratek's Officers Sued In Del. Over $462M Sale
- Biotech Nabs $200M Via Private Placement, Starts CEO Search
- Fox News' Sorrento Report Takes Center Stage At 9th Circ.
- SmileDirectClub Trustee Wants To Cut Leases To Stop Losses
- GSK Exec Joins Troutman Pepper's Life Sciences IP Team
- Coaching High School Wrestling Makes Me A Better Lawyer
- Dentists Can't Get Class Certification In SmileDirectClub Suit
- Genetic Testing Co. Invitae Files For Ch. 11 With $1.5B Debt
- 6th Circ. Backs Drugmakers' Early Win In Diabetes Drug MDL
- Indian Pharma Co. Can't Get Fees In $950M COVID Vax Suit
- Expert's 11th-Hour Change Blocked In Pet Device IP Retrial
- Insurers Must Pay Pharma Co. Defense Costs In SEC Probe
- FDA, Creditors Oppose Drugmaker Humanigen's Ch. 11 Sale
- Texas Appeals Court Grants Medical Coding Co.'s Atty Fee Bid
- Biden Administration Beats Big Pharma Texas Medicare Suit
- New Rule 702 Helps Judges Keep Bad Science Out Of Court
- SG's Office Is Case Study To Help Close Legal Gender Gap
- Ky. Alleges Kroger Had 'Outsized' Role In State's Opioid Crisis
- Mallinckrodt Guts IP Suit Amid Oxide Rival's New Drug App
- Fox Rothschild Beefs Up Government Contracts Team In DC
- Breast Implant Maker Sientra Hits Ch. 11 With $82M In Debt
- Investors Win Class Cert. Against Failed COVID Test Maker
- Alys Pharmaceuticals Launches With $100M In Financing
- Patent Waiver For COVID Meds Would Harm US Biopharma
- Ind. Seed Lab Property Exempt From Tax, Board Says
- Fish & Richardson Launches Life Sciences Group
- Gilead Buying Liver Disease Drugmaker CymaBay For $4.3B
- No More Shady Trading For Ex-FBI Trainee After BigLaw Theft
- DEA Wrong To Block Psilocybin Therapy, 9th Circ. Told
- Pharma Co. Beats Investor Suit Over Licensing Agreement
- Fed. Circ. Backs Gov't Win In Fla. University's Patent Dispute
- Former Pharma Exec Faces Criminal Contempt For Fake Name
- AI Drugmaker Wants Investor Suit Over Botched Trial Tossed
- Healthcare-Focused SPAC Hits The Market After $160M IPO
- FTC Clears AbbVie To Proceed With $10.1B ImmunoGen Buy
- Humanigen Creditors Say DIP Loan Ties Up Too Many Assets
- Conn. Justices Asked To Rule On McCarter Damages Dispute
- Goodwin-Led Gene Editing Firm Metagenomi Raises $94M IPO
- What To Know About 'Novel' Johnson & Johnson ERISA Suit
- 23andMe Led To Late Father And $28M Verdict, Woman Says
- UK Litigation Roundup: Here's What You Missed In London
- $490M FCA Verdict Against Medical Distributor Cut In Half
- White House Patent Plan To Curb Drug Prices Draws Outcry
- SEC Fights Hedge Fund Priest's Fee Bid After Mixed Verdict
- BioNTech Puts $200M Into Collab With Cancer Biotech Autolus
- HHS Won't Invoke IP Rights To Lessen Xtandi Prices
- Biotech Co. Neurona Therapeutics Raises $120M
- Judge Drops Claim From Biotech Ex-VP's Incentive Pay Suit
- FDA Settles Allegations Of Uneven Blood Treatment Standards
- Pharma Cos. Back Request For Justices To Eye Drug IP Case
- Mich. Counties Sue Drug Giants Over Insulin Prices
- Drugmaker Challenges W.Va. Abortion Ban In 4th Circ.
- Investors Sue In Del. For Cartesian Therapeutics Vote Hold
- Skirting Anti-Kickback Causation Standard Amid Circuit Split
- These Firms Are Leading In Patent Litigation Work
- These Firms Are Leading In PTAB Work
- Exelixis GC Joins Board Of Biocom California Organization
- Philips Rival Seeks Interest After Treble Damages Award
- Paul Hastings, Covington Guide Kyverna's Upsized $319M IPO
- Morgan Lewis Adds Hawkins Parnell Toxic Tort Litigator In LA
- EDTX Eclipses WDTX As Top Patent Venue
- PTAB Filings Drop Alongside Declining Patent Litigation
- New Patent Suits Fall To Lowest Level In Over A Decade
- 2nd Circ. Skeptical Of Reviving Investors' Breast Implant Suit
- US Tells 9th Circ. Stem Cell Clinic Not Exempt From FDA Rules
- Fluoride Judge To Attys: 'I Don't Need Perry Mason Moments'
- Life Sciences VC Scion Launches With $310M Fund
- Fla. Justices Hesitant To Limit Abortion Ballot Measure
- Wash. High Court Won't Review J&J Patient Privacy Ruling
- Surgical Robot Co. Sued Over Internal Burns, Death Of Patient
- GOP Lawmakers, AG Spar Over NC Abortion Medication Limits
- Pfizer, Moderna Spar Over Trial Date In COVID Vaccine IP Case
- Acella's $46.5M Drug Recall Settlement Gets Initial Signoff
- Worker Says J&J Mismanaged Prescription Benefits
- 10 Lessons From A Deep Dive Into IP Damages
- Pharma Co. Asks D.C. Judge To Ax FDA's Deadline 'Hall Pass'
- Ward & Smith Nabs $170K Fee In NC Trade Secrets Fight
- What Shareholder Approval Rule Changes Mean For Cos.
- Reimagining Law Firm Culture To Break The Cycle Of Burnout
- Apple Defeats Antitrust Suit By AliveCor Over Apple Watch
- Calif. Lawmakers Pitch New Psychedelics Treatment Bill
- 10th Circ. Affirms $4.7M Stryker Loss, But Tosses Fee Award
- Pacira Touts Stability Upgrade In Pain Drug Patent Trial
- Judge Will Screen Ex-CEO's Filings In Stimwave Ch. 11
- JPML Consolidates Suboxone Dental Decay Suits In Ohio
- 6th Circ. Backs Becton's Win In Royalties Suit
- Expediting Psychedelics Approvals In The EU, UK, Australia
- ESG Around The World: Brazil
- Gilead Ruling Signals That Innovating Can Lead To Liability
- Vidal Should Amend USPTO Precedent In Automaker Review
- NanoString Can Tap $142.5M DIP As It Weighs Ch. 11 Sale
- Grant Compliance Takeaways From Ga. Tech's FCA Settlement
- Competing In Dressage Makes Me A Better Lawyer
- Freshfields Helps Novartis Buy German Pharma In €2.7B Deal
- Psychedelics Bill Roundup: Mass. Proposal Enters Legislature
- 7th Circ. Wary Of Bid To Revive Abbott Formula Claims
- Proposed Class Action Settlement May Cost Acella $46.5M
- Biotech Co. Hit With Investor Suit Over Alzheimer's Drug Trial
- Ozempic Injury Suits Consolidated In Eastern Pa. MDL
- Ga. Sues Federal Gov't Over Medicaid Expansion Program
- Biotech Co. Hits Ch. 11, Blames Drug Misfires, Criminal Case
- CPAP Cleaner Co. Says Philips Can't Pin Recall On It
- Zymergen Ch. 11 Plan Confirmed After Investor Objection
- Teva Asks Fed. Circ. To Examine $177M Verdict Reversal
- Gene-Editing Firm Taps IPO Wave With Plans To Raise $100M
- 3 Firms Guide Merck Animal Health's $1.3B Buy Of Fish Biz
- Spinal Implant Maker Previews Ch. 11 Sale And Wind Down
- Biotech Co. NanoString Hits Ch. 11 In Del. With $325M Debt
- Novo Holdings Buying Biopharma Co. Catalent In $16.5B Deal
- Eli Lilly, Sanofi Beat Antitrust Suit Alleging Insulin Conspiracy
- McKinsey's $78M Opioid Deal With Health Plans Hits Snag
- USPTO Slams Lundbeck's PTSD Drug Patent Term Suit
- 4th Circ. Vacates Va. Doctor's Conviction In Pill Mill Scheme
- Harvard Prof. Slams Study Showing IQ Gains From Fluoride
- ABA Chides 5th Circ. At High Court Over Mifepristone Ruling
- Judge Tosses Involuntary Releases In Amyris Ch. 11 Plan
- Drugmaker Endo Wants To Extend Opioid Suit Pause
- ACLU Atty On How To Protect Civil Liberties In The AI Era
- Families New To Tylenol MDL Cite Expert To Avoid Dismissal
- Latham Led Firms In January IPOs As New Listings Pick Up
- Ascension Says Medical Queries Don't Breach Genetic Privacy
- Pennsylvania AG's Clout In Opioid Deal Likely Has Wide Reach
- How Poor Governance, Weak Contracts Harm Cannabis Cos.
- McCarter & English To Face Revised Biotech Malpractice Suit
- DLA Piper Hires McDermott's FDA Practice Leader In DC
- UK Regulator Examining Thermo Fisher's $3.1B Olink Buy
- 2 Biotech Firms Tap Thawing IPO Market To Raise $239M Total
- Del. Ruling Adds Momentum For Caremark Plaintiffs
- Ex-FDA Leaders Urge High Court To Nix Mifepristone Ruling
- Harvard Professor Testifies Fluoride Is 'Definitely' Neurotoxic
- Stimwave Trustee Seeks Stay Of Perryman Actions In Ch. 11
- Pharma Hikma Reaches $150M Opioid Settlement With States
- Assa Abloy Nabs PTAB Win Against Biometric Security Patent
- Denver Man Accused Of Romancing Women Into $121K Scam
- Bankrupt Pharma Co. Impel Gets OK For $17.5M Sale
- Conn. Supreme Court Snapshot: Sleepy Juror, Surprise Billing
- NJ Says Constitution Doesn't Protect Medical Aid In Dying
- Life Sciences VC Firm Seroba Closes $134M Fund
- Mich. High Court To Consider Lilly Insulin Pricing Probe
- State-Led Generic Drug Cases Removed From MDL
- How Biotech Cos. Can Utilize Synthetic Royalty Financing
- Spinal Implant Maker Eyes Ch. 11 Wind-Down In Del.
- Publicis Reaches $350M Opioid Settlement With All 50 States
- Cell Therapy Firm Kyverna Eyes $200M IPO As Pipeline Builds
- The Legal Industry Needs A Cybersecurity Paradigm Shift